These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8605148)

  • 21. Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies.
    Schlott B; Wöhnert J; Icke C; Hartmann M; Ramachandran R; Gührs KH; Glusa E; Flemming J; Görlach M; Grosse F; Ohlenschläger O
    J Mol Biol; 2002 Apr; 318(2):533-46. PubMed ID: 12051857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of noncovalent trypsin inhibitor based on the X-ray crystal structure of the complex.
    Nakamura M; Tomoo K; Ishida T; Taguchi H; Tsuda Y; Okada Y; Okunomiya A; Wanaka K; Okamoto S
    Biochem Biophys Res Commun; 1995 Aug; 213(2):583-7. PubMed ID: 7646515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
    Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
    J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of the complex of trypsin with a highly potent synthetic inhibitor at 0.97 A resolution.
    Sherawat M; Kaur P; Perbandt M; Betzel C; Slusarchyk WA; Bisacchi GS; Chang C; Jacobson BL; Einspahr HM; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2007 Apr; 63(Pt 4):500-7. PubMed ID: 17372355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
    J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
    Bode W; Turk D; Karshikov A
    Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes.
    Helland R; Berglund GI; Otlewski J; Apostoluk W; Andersen OA; Willassen NP; Smalås AO
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):139-48. PubMed ID: 10089404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition.
    Dullweber F; Stubbs MT; Musil D; Stürzebecher J; Klebe G
    J Mol Biol; 2001 Oct; 313(3):593-614. PubMed ID: 11676542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.
    Jhoti H; Cleasby A; Reid S; Thomas PJ; Weir M; Wonacott A
    Biochemistry; 1999 Jun; 38(25):7969-77. PubMed ID: 10387040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
    Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
    J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the insertion loop around tryptophan 148 in tthe activity of thrombin.
    DiBella EE; Scheraga HA
    Biochemistry; 1996 Apr; 35(14):4427-33. PubMed ID: 8605192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker.
    Slon-Usakiewicz JJ; Purisima E; Tsuda Y; Sulea T; Pedyczak A; Féthière J; Cygler M; Konishi Y
    Biochemistry; 1997 Nov; 36(44):13494-502. PubMed ID: 9354617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
    Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
    Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors.
    Schweizer E; Hoffmann-Röder A; Olsen JA; Seiler P; Obst-Sander U; Wagner B; Kansy M; Banner DW; Diederich F
    Org Biomol Chem; 2006 Jun; 4(12):2364-75. PubMed ID: 16763681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of mung bean inhibitor lysine active fragment complex with bovine beta-trypsin at 1.8A resolution.
    Zhu Y; Huang Q; Chi C
    J Biomol Struct Dyn; 1999 Jun; 16(6):1219-24. PubMed ID: 10447205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
    Chirgadze NY; Sall DJ; Klimkowski VJ; Clawson DK; Briggs SL; Hermann R; Smith GF; Gifford-Moore DS; Wery JP
    Protein Sci; 1997 Jul; 6(7):1412-7. PubMed ID: 9232642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The crystal structure of alpha-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode.
    Lombardi A; De Simone G; Nastri F; Galdiero S; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V
    Protein Sci; 1999 Jan; 8(1):91-5. PubMed ID: 10210187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
    J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK; Grossmann JG; Zaidi ZH
    J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The crystal structure of phosphonate-inhibited D-Ala-D-Ala peptidase reveals an analogue of a tetrahedral transition state.
    Silvaggi NR; Anderson JW; Brinsmade SR; Pratt RF; Kelly JA
    Biochemistry; 2003 Feb; 42(5):1199-208. PubMed ID: 12564922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.